In the wake of the COVID-19 crisis, many sub-Saharan African countries will face serious economic crises and shrinking public spending. If countries are unable to spend more, they need to spend better. Europe has leading expertise in building institutions for priority-setting in health, making it an obvious potential source for collaboration with the Global South.
CGD Policy Blogs
We Must Stop Flying Blind: Building on Existing Systems In Low- and Middle-Income Countries To Improve the COVID-19 Response
COVID- 19 has brought a sense of urgency to decision-making that typically would have taken many months and years of deliberation. Central to this uncertainty is the glaring lack of knowledge on just how big the burden of COVID-19 truly is. The pandemic has highlighted concerning gaps in data and weaknesses in surveillance systems that have long hampered public health systems globally, especially in low- and middle- income countries (LMIC).
As the world battles COVID-19, practical investments are urgently needed to ensure that decision-makers consult the best and most relevant evidence on COVID-19 before making a decision.
The authors look at the feasibility of the drug dexamethasone in low-income countries.
Following precedents applied first in wealthy states, more than 140 countries have applied some form of lockdown restrictions to slow their COVID-19 epidemics, but can control measures be made sustainable in low-income countries?
With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies. This includes identifying the right subpopulations and negotiating a cost-effective tiered price across countries and regions.
Maintaining Essential Services in the Time of COVID-19: Vaccination Delivery in Low- and Middle-Income Countries
As we observe World Immunisation Week, the implications of COVID-19’s spread for routine childhood vaccination delivery are already becoming clear.
iDSI is a global network of health, policy, and economic expertise that works to directly strengthen priority-setting methods, capacity and processes, and respond to demand for knowledge diffusion and translation. Learn more about iDSI and CGD's priority setting work.
This blog focuses on hospital treatment for COVID-19 patients in low-resource-settings, considering what we know about the spectrum of COVID-19 illness and what this tells us about where resources might best be focused in low-resource-settings. As elsewhere, decision makers, global and local, must prioritise resourcing and capacity development for the ward-level care and simple oxygen therapy that most hospitalised COVID-19 patients will need—not the high-end clinical care that may well be impossible to scale-up in time in countries with limited resources.